Site icon PubCoCEO™

Only One OTC Markets Issuer Uplisted From The OTC In June 2019

 

Only One OTC Markets Issuer Uplisted From The OTC In June 2019

Only one OTC Markets Issuer Uplisted From The OTC To a senior exchange in June 2019. Learn more about the sole OTC ‘graduate’ below.

Artelo Biosciences, Inc. (Nasdaq: ARTL)

On June 21, 2019, ARTL uplisted from the OTCQB to the Nasdaq Capital Market. Artelo Biosciences is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system.

In connection with the uplisting, ARTL closed an $8 million underwritten public offering of 1,300,813 units at a price to the public of $6.15 per unit. Maxim Group LLC acted as the Sole Book-Running Manager and Joseph Gunnar & Co. acted as co-manager for the offering.

 


 

Exit mobile version